Qube Research & Technologies (QRT)
ELAN icon

Qube Research & Technologies (QRT)’s Elanco Animal Health ELAN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-181,994
Closed -$2.63M – 3506
2024
Q2 		$2.63M Sell
181,994
-188,269
-51% -$3.01M ﹤0.01% 1511
2024
Q1 		$6.03M Buy
370,263
+239,758
+184% +$3.75M 0.01% 1125
2023
Q4 		$1.94M Buy
130,505
+128,805
+7,577% +$1.46M ﹤0.01% 1544
2023
Q3 		$19.1K Sell
1,700
-421,346
-100% -$4.89M ﹤0.01% 3163
2023
Q2 		$4.26M Sell
423,046
-82,230
-16% -$763K 0.02% 744
2023
Q1 		$4.75M Sell
505,276
-1,345,146
-73% -$15.9M 0.02% 687
2022
Q4 		$22.6M Buy
1,850,422
+1,016,981
+122% +$12.7M 0.12% 247
2022
Q3 		$10.3M Buy
833,441
+25,558
+3% +$447K 0.06% 400
2022
Q2 		$15.9M Buy
807,883
+237,902
+42% +$5.63M 0.12% 221
2022
Q1 		$14.9M Sell
569,981
-75,188
-12% -$2M 0.13% 214
2021
Q4 		$18.3M Buy
+645,169
New +$20.1M 0.14% 172
2021
Q3 		– Sell
-57,265
Closed -$1.99M – 2345
2021
Q2 		$1.99M Buy
+57,265
New +$1.89M 0.02% 701
2021
Q1 		– Sell
-61,307
Closed -$1.88M – 2028
2020
Q4 		$1.88M Buy
+61,307
New +$1.87M 0.03% 644
2020
Q3 		– Sell
-10,890
Closed -$234K – 1779
2020
Q2 		$234K Buy
10,890
+922
+9% +$20.4K ﹤0.01% 1384
2020
Q1 		$223K Sell
9,968
-1,085
-10% -$29.7K 0.01% 829
2019
Q4 		$326K Buy
+11,053
New +$300K 0.01% 1184
2019
Q2 		– Sell
-24,655
Closed -$791K – 446
2019
Q1 		$791K Buy
+24,655
New +$759K 0.1% 257

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELAN Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Elanco Animal Health (ELAN) in Q3 2024, closing a stake of 181,994 shares — an estimated $2.63M sold.

Qube Research & Technologies (QRT) first reported a position in ELAN in Q1 2019 and held it in 17 quarters. The position peaked at $22.6M in Q4 2022. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Elanco Animal Health position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 181,994 Elanco Animal Health shares in Q3 2024, an estimated $2.63M.
  • Qube Research & Technologies (QRT) first reported a position in Elanco Animal Health in Q1 2019 and held it in 17 quarters.
  • Qube Research & Technologies (QRT)'s Elanco Animal Health position peaked at $22.6M in Q4 2022.
  • 388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.